Abstract:
PROBLEM TO BE SOLVED: To provide a system which enables glycemic control for a patient control. SOLUTION: The system, which enables the glycemic control for the patient control, includes an insulin delivering means (12), a glucose sensor (16), and a controlling means (14). The controlling means (14) includes a processing means which receives a glucose value record from the glucose sensor (16), performs an algorithm which predicts a future glucose value at a predetermined time, compares the predicted glucose value to a predetermined glucose value range, and decides a corrective amount of insulin when the predicted glucose value is outside the range of the predetermined glucose value range. The controlling means (14) also includes a communication means which transmits the corrective amount to the delivering means. COPYRIGHT: (C)2006,JPO&NCIPI
Abstract:
PROBLEM TO BE SOLVED: To provide a system which makes blood sugar control for a patient possible. SOLUTION: The system for making the blood sugar control for the patient possible has insulin delivering means, glucose sensor and control means. The control means has processing means of receiving a glucose value record from the glucose sensor, executing an algorithm to predict a future glucose value in the predetermined time, comparing the predicted glucose value and the preset glucose value range and determining a corrective amount of insulin when the predicted glucose value is off the preset glucose value range. The control means also has transmission means for transmitting the corrective amount to the delivering means.
Abstract:
A method is disclosed for providing therapeutic guidelines to a person having diabetes. The method comprises measuring a blood glucose (bG) level of the person for two or more days, wherein at least one bG measurement is taken per day, and the at least one daily bG measurement corresponds to one or more daily events for the person; recording the measured bG levels in a computing device; determining, by the computing device, whether the recorded bG levels are below, within, or above one or more predetermined bG ranges; an automatically providing, by the computing device, therapeutic guidelines to the person, based on whether the recorded bG levels are below, within, or above the one or more predetermined bG ranges.
Abstract:
Embodiments related to a system and method managing the implementation, execution, data collection, data analysis and status reporting of a structured collection procedure running on a portable, hand-held collection device are disclosed. The collection device performing the structured collection procedure has program instructions that when executed by a processor cause the processor to initiate automatically a schedule of events of the structured collection procedure upon one or more entry criteria being met at some unknown time, store in memory patient data collected in accordance to the schedule of events, end automatically the structured collection procedure upon one or more exit criteria being met at some unknown time. Status reporting can be provided throughout the execution of the collection procedure.
Abstract:
Embodiments related to a system (41) and method (200, 300, 388, 400) managing the implementation, execution, data collection, and data analysis of a structured collection procedure (70) running on a portable, hand-held collection device (24) are disclosed. The collection device (24) performing the structured collection procedure (70) has program (34) instructions that when executed by a processor (102) causes the processor (102) to initiate automatically a schedule of events (222) of the structured collection procedure (70) upon one or more entry criterions (226) being met at some unknown time, store in memory (110) patient data (256, 170, 145) collected in accordance to the schedule of events (222), end automatically the structured collection procedure (70) upon one or more exit criterions (228) being met at some unknown time, and mark/indicate the structured collection procedure (70) as completed if no exception occurred during performance of an event (237) in the schedule of events (222).
Abstract:
A patient interface for a therapy system allows a patient to input information that characterizes at least one patient event or condition and from which therapy information can be determined. The patient interface may illustratively be formed by developing a patient model that is configured to simulate the patient's physiological response to the at least one patient event or condition, collecting patient-specific information over time that relates to actual occurrences of the at least one patient event or condition, and defining a graphical interface, based on the patient model and on the collected patient- specific information, that maps input from the patient of the information that characterizes the at least one patient event or condition to corresponding therapy information.
Abstract:
An adherence indication tool for chronic disease self-management and method thereof for measuring adherence or compliance to following or achieving prescribed therapy steps to achieve stated target goals for improved chronic disease self-management are disclosed.
Abstract:
A system for determining drug administration information may comprise an input device providing for user input of feed forward information having a first parameter component and a second parameter component, a data storage device and a processor. The data storage de-vice may have stored therein a map correlating values of the first and second parameters to drug administration information. The processor may be responsive to user input of the feed forward information to determine corresponding drug administration information according to the map.
Abstract:
An adherence indication tool for chronic disease self-management and method thereof for measuring adherence or compliance to following or achieving prescribed therapy steps to achieve stated target goals for improved chronic disease self-management are disclosed.
Abstract:
A structured testing method (200, 300, 388) for diagnostic or therapy support of a patient (12) with a chronic disease and devices (18) thereof are disclosed, devices (18) implement the structured collection procedure (70) based on a medical use case and/or question which provides at least one or more parameters (220, 222, 224, 226, 228, 230, 232, 237, 238, 240) defining at least one entry criterion (226), a schedule of events (222), at least one adherence criterion (224), and at least one exit criterion (228). The entry criterion (226) establish conditions needed to be met prior to obtaining biomarker data (256) from the patient (12). Each event (237) in the schedule of events (222) can include at least one or more of a performance time (238), guidance (230) to perform the event (237), a request (240) for information from the patient (12), a request (240) for patient action, and a request (240) for collection of at least one type of biomarker data (256) from the patient (12). The adherence criterion (224) is used to assess qualitatively whether an event (237) performed according to the schedule of events (222) provided data (256, 170, 145) which is acceptable to addressing the medical use case and/or question, and the exit criterion (228) establishes conditions needed to be met prior to exiting the structured collection procedure (70).